Elequin Capital LP Immunocore Holdings PLC Transaction History
Elequin Capital LP
- $825 Million
- Q4 2024
A detailed history of Elequin Capital LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Elequin Capital LP holds 73 shares of IMCR stock, worth $2,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73
Previous 43
69.77%
Holding current value
$2,176
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$200 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$145 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79.5 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$65.2 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.31B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...